Description
BPC-157 & TB-500 & GHK-Cu Blend
BPC-157 is a synthetic 15–amino acid peptide thought to originate from a fragment of a gastric protein, although its exact source protein has not been definitively identified. Experimental models suggest it may influence intracellular pathways involved in angiogenesis and may help regulate inflammatory processes by dampening pro-inflammatory signaling cascades. (1)
TB-500 is a synthetic peptide identical to thymosin beta-4, a naturally occurring 43–amino acid peptide associated with cell migration, cytoskeletal organization, and inflammation-related signaling. In vitro research indicates it may support cellular movement and structural coordination while also contributing to angiogenic signaling and modulation of inflammatory mediators. (2)
GHK-Cu is a naturally occurring tripeptide (glycine–histidine–lysine) bound to copper (Cu²⁺). It is believed to be released during tissue injury by cells such as fibroblasts, macrophages, and lymphocytes as a byproduct of collagen breakdown. (3) This complex is thought to function as a biological repair signal, interacting with enzymes, receptors, and ion channels and influencing gene expression. The copper component is considered important for effects related to collagen production, antioxidant activity, and inflammation modulation.
Together, these peptides may exhibit overlapping and complementary biological activities, leading to the hypothesis that combined exposure could beneficially influence inflammatory regulation and tissue repair processes, including vascular and cellular regeneration.
Chemical Makeup
Alternative names:
- BPC-157: C62H98N16O22
- TB-500: C212H350N56O78S
- GHK-Cu: C14H23CuN6O4
Molecular weights:
- BPC-157: ~5 g/mol (as listed)
- TB-500: 4963 g/mol
- GHK-Cu: ~38 g/mol
Molecular formulas:
- BPC-157: Body Protection Compound-157
- TB-500: Synthetic Thymosin Beta-4
- GHK-Cu: glycyl-histidyl-lysine copper complex
Research and Clinical Studies
Anti-inflammatory signaling
All three peptides have been studied for potential roles in moderating inflammatory processes at the cellular level.
Research by Santra et al. suggests TB-500 may reduce inflammatory signaling in oligodendrocyte progenitor cells by increasing miR-146a, a regulatory microRNA involved in suppressing innate immune pathways. Elevated miR-146a can reduce IRAK1 and TRAF6 expression, thereby limiting NF-κB activation and downstream inflammatory signaling. (4)
BPC-157 has also been shown in experimental models (Sikiric et al.) to reduce inflammatory cell infiltration and lower markers such as neutrophil accumulation, leukotriene B4, and thromboxane B2. (5) It may also influence macrophage behavior in a way that supports resolution of inflammation rather than prolongation. Additionally, it is suggested to interact with the nitric oxide (NO) system, potentially helping preserve endothelial integrity and limiting inflammatory escalation.
GHK-Cu has demonstrated anti-inflammatory effects in macrophage and lung injury models. Park et al. reported reduced reactive oxygen species, restoration of antioxidant enzyme activity, and decreased TNF-α and IL-6 levels following treatment. (6) It may also suppress NF-κB signaling, leading to reduced inflammatory cytokine production and improved tissue integrity in experimental lung injury models.
Cellular regeneration and angiogenesis
Beyond inflammation modulation, these peptides are also associated with regenerative processes such as angiogenesis and tissue repair.
TB-500 is thought to promote regeneration by influencing actin dynamics and enhancing cellular motility. Lv et al. reported that it binds to globular actin and affects cytoskeletal organization, improving endothelial cell migration and structural flexibility. (7) This may facilitate angiogenesis, including tube formation and increased expression of VEGFA, angiopoietin-2, and Tie2 through signaling pathways involving Notch and NF-κB.
BPC-157 has also been linked to vascular protection and angiogenesis. Sikiric et al. suggest it helps maintain endothelial integrity and supports vessel stability, creating favorable conditions for new vessel formation. (8) It has been associated with signaling pathways such as Egr-1/NAB2 and FAK–paxillin, which regulate cell adhesion and migration, as well as normalization of nitric oxide signaling, which is important for vascular repair and remodeling.
GHK-Cu has been shown to stimulate angiogenic activity by increasing VEGF expression and promoting endothelial cell proliferation and migration. (9) Its copper component is also important for enzymatic processes involved in angiogenesis and tissue regeneration, particularly at sites of injury.
Collagen and tissue repair
All three peptides have been studied for their potential roles in collagen remodeling and tissue repair, particularly in connective tissues.
TB-500 has been shown (Xu et al.) to improve tendon healing by enhancing collagen fiber organization and alignment, resulting in improved structural strength and mechanical properties. (10)
BPC-157 has been associated with increased fibroblast migration, survival, and cytoskeletal organization, supporting faster tissue repair. It has also been linked to improved actin filament formation and activation of focal adhesion pathways such as FAK and paxillin, which are important for cell attachment and movement. (11)
GHK-Cu may also enhance collagen synthesis and improve integration between tendon and bone tissue. Fu et al. reported improved tissue regeneration and increased cellular presence in graft models exposed to the peptide. (12)
Overall, the three peptides may contribute to tissue repair through combined effects on inflammation control, vascular growth, and extracellular matrix remodeling, although combined experimental evaluation remains limited.
BPC-157 & TB-500 & GHK-Cu blend is intended for research and laboratory use only.
Reviews
There are no reviews yet.